September 15, 2022: Marcia P Jimenez, Boston University &  L. Paloma Rojas-Saunero, UCLA “Racial and ethnic differences in the risk of dementia under hypothetical blood-pressure-lowering interventions: The Multi-Ethnic Study of Atherosclerosis.”

Marcia P Jimenez &  L. Paloma Rojas-Saunero


November 18, 2021: Madhav Thambisetty, NIA/NIH, “From Mechanisms to Medicines: realizing the DREAM of an Alzheimer’s cure.”


October 28, 2021: Venexia Walker, University of Bristol, “Predicting drug repurposing opportunities for Alzheimer’s disease prevention using genome-wide association study data”


October 8, 2021: Maria Glymous, UCSF, “Introduction to using Directed Acyclic Graphs in dementia research”


September 15, 2021: Ryan Andrews, Boston University School of Public Health, “Meditations on Mediation Analysis”

Ryan Andrews

September 2, 2021: Michelle Odden, Stanford University, “Collider Stratification Bias in Studies of Dementia: Mountain or Molehill?”

Michelle Odden

July 15, 2021: Thomas Nedelec, Paris Brain Institute, “Data-driven identification of health conditions associated with incident Alzheimer’s disease dementia risk: a 15 years follow-up cohort from electronic health records in France and the United Kingdom”


June 3, 2021: L. Paloma Rojas-Saunero, Erasmus MC, “Dissecting the causal question underlying the association between cancer and dementia”

L. Paloma Rojas-Saunero

April 1, 2021: Zach Baucom, Boston University School of Public Health, “Using State Space Models for Longitudinal Neuropsychological Outcomes”


March 18, 2021: Lon Schneider, University of Southern California, “Methodological features and FDA’s regulatory guidance on aducanumab and Alzheimer drug development”

Lon Schneider


October 15, 2020: Deborah Blacker & Sudeshna Seshadri, Harvard Medical School/Massachusetts General Hospital, “Towards Real-World Data for Dementia Studies: Use of machine-learning to improve metrics”

Sudeshna Seshadri & Deborah Blacker

July 9, 2020: Bryan James, Rush Alzheimer’s Disease Center, “Implications of covid for dementia researchers”

Bryan James

May 7, 2020: Jonathan Jackson, Harvard Medical School/Massachusetts General Hospital, “The Challenge of Health Equity in Clinical Research: Towards a Quantifiable Science of Inclusion.”

Jonathan Jackson